(Q36324991)

English

Quantitative evaluation of viable tissue perfusion changes with contrast-enhanced greyscale ultrasound in a mouse hepatoma model following treatment with different doses of thalidomide

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Quantitative evaluation of viable tissue perfusion changes with contrast-enhanced greyscale ultrasound in a mouse hepatoma model following treatment with different doses of thalidomide (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

J H Zhou

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

W Zheng

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

L H Cao

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

M Liu

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

R Z Luo

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

F Han

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

P H Wu

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

A H Li

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

11 January 2011

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

British Journal of Radiology

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

84

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1005

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

826-832

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Antiangiogenic tumor treatment: noninvasive monitoring with contrast pulse sequence imaging for contrast-enhanced grayscale ultrasound

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Imaging of angiogenesis: clinical techniques and novel imaging methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Functional imaging in CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Imaging angiogenesis: applications and potential for drug development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Vasculogenic mimicry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Measuring tumour vascular response to antivascular and antiangiogenic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Thalidomide in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Quantification of blood flow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Tumor angiogenesis: therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

30 September 2017

Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

29 June 2018

Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion: preliminary results

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F14335925

21 January 2018

Early quantitative evaluation of a tumor vasculature disruptive agent AVE8062 using dynamic contrast-enhanced ultrasonography

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F14335925

21 January 2018

Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F14335925

21 January 2018

Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F14335925

21 January 2018

Perfusion CT for head and neck tumors: pilot study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

22 September 2018

Contrast-agent detection and quantification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3473775

22 September 2018

Darstellbarkeit kleinster Tumorgefäße mit Hilfe der Farbdopplersonographie im Experiment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21224299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21224299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1259/BJR/14335925

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36324991&oldid=1519413678"